EMAIL THIS PAGE TO A FRIEND

British journal of cancer

Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.


PMID 24809783

Abstract

Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontaneous mammary tumour development caused by loss of tumour suppressor genes such as p53 is lacking. Alterations in the tumour suppressor gene p53 have been implicated in over 50% of human breast cancers. Given that elevated FAK expression highly correlates with p53 mutation status in human breast cancer, we set out to investigate the importance of FAK in p53-mediated spontaneous mammary tumour development. To directly assess the role of FAK, we generated mice with conditional inactivation of FAK and p53. We generated female p53(lox/lox)/FAK(+/+)/WapCre, p53(lox/lox)/FAK(flox/+)/WapCre and p53(lox/lox)/FAK(flox/-)/WapCre mice, and mice with WapCre-mediated conditional expression of p53(R270H), the mouse equivalent of human p53(R273H) hot spot mutation, together with conditional deletion of FAK, P53(R270H/+)/FAK(lox/+)/WapCre and p53(R270H/+)/FAK(flox/-)/WapCre mice. All mice were subjected to one pregnancy to induce WapCre-mediated deletion of p53 or expression of p53 R270H, and Fak genes flanked by two loxP sites, and subsequently followed the development of mammary tumours. Using this approach, we show that FAK is important for p53-induced mammary tumour development. In addition, mice with the mammary gland-specific conditional expression of p53 point mutation R270H, the mouse equivalent to human R273H, in combination with conditional deletion of Fak showed reduced incidence of p53(R270H)-induced mammary tumours. In both models these effects of FAK were related to reduced proliferation in preneoplastic lesions in the mammary gland ductal structures. Mammary gland-specific ablation of FAK hampers p53-regulated spontaneous mammary tumour formation. Focal adhesion kinase deletion reduced proliferative capacity of p53 null and p53(R270H) mammary epithelial cells but did not lead to increased apoptosis in vivo. Our data identify FAK as an important regulator in mammary epithelial cell proliferation in p53-mediated and p53(R270H)-induced mammary tumour development.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

05-537
Anti-FAK Antibody, clone 4.47, Anti-FAK Antibody, clone 4.47 is an antibody against FAK for use in IC, IH, IP & WB.
GW21186 Anti-CDH1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2501665
Anti-CDH1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2701861
Anti-cdh1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA004812
Anti-CDH1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104222
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB4300693
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB2107370
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB4300665
Anti-FAK (Ab-397) antibody produced in rabbit, affinity isolated antibody
SAB4502495
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502496
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502498
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502499
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502503
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4501653
Anti-Keratin 8 antibody produced in rabbit, affinity isolated antibody
HPA059479
Anti-KRT5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410739
Anti-KRT5 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4300552
Anti-KRT8 (Ab-74) antibody produced in rabbit, affinity isolated antibody
AV42028
Anti-KRT8 (AB1) antibody produced in rabbit, affinity isolated antibody
AV42029
Anti-KRT8 (AB2) antibody produced in rabbit, affinity isolated antibody
SAB1406070
Anti-KRT8 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2701923
Anti-krt8 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701925
Anti-krt8 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701684
Anti-krt8 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA049866
Anti-KRT8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1306667
ANTI-P53 (S15) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306713
ANTI-P53 (S315) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306623
ANTI-P53 (SUMOYLATION SITE SPECIFIC) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
P4235 Anti-p53 antibody produced in sheep, fractionated antiserum, buffered aqueous solution
SAB4300597
Anti-PTK2 (Ab-576/577) antibody produced in rabbit, affinity isolated antibody